Brawn Biotech Ltd's earnings have grown by 12.8%, whereas share price has declined -19.5% CAGR over the past five years, indicating the company’s share price is likely undervalued. However, for specific investment actions please consult your investment advisor.
Brawn Biotech Ltd share price has appreciated 11.4% annually (CAGR) over the past ten years.
Data is not available for this company.
Brawn Pharmaceuticals was incorporated in the year 1985 it operates in health care sector in India and outside India. It has started its business by selling pharmaceutical formulations manufactured by other companyâ€™s loan license basis. The company is located in New Delhi, India.
The company involves in the manufacture, contract manufacture, and supply of pharmaceutical products. It is basically
The company involves in the manufacture, contract manufacture, and supply of pharmaceutical products. It is basically engages in the manufacture of tablets, capsules, and oral syrups.
Products of the company
Company's products are made under various categories namely Analgesics, Antibiotics, Anti Tuberculosis, Anti-inflammatory, Antipyretic, Anti Malarial, B Complex and Amino Acids, Cardiovascular drugs, Antiphyscotropic drugs, Tranquilizers, Antacids.